1. Home
  2. ATLO vs CRBP Comparison

ATLO vs CRBP Comparison

Compare ATLO & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$27.38

Market Cap

205.2M

Sector

Finance

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$7.77

Market Cap

170.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLO
CRBP
Founded
1903
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.2M
170.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ATLO
CRBP
Price
$27.38
$7.77
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$50.29
AVG Volume (30 Days)
36.7K
162.1K
Earning Date
01-23-2026
03-10-2026
Dividend Yield
2.92%
N/A
EPS Growth
88.22
N/A
EPS
2.14
N/A
Revenue
$65,795,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$220.00
P/E Ratio
$12.80
N/A
Revenue Growth
23.09
N/A
52 Week Low
$16.09
$4.64
52 Week High
$28.35
$20.56

Technical Indicators

Market Signals
Indicator
ATLO
CRBP
Relative Strength Index (RSI) 74.19 41.61
Support Level $27.06 $7.33
Resistance Level $28.35 $8.23
Average True Range (ATR) 0.74 0.59
MACD 0.07 -0.04
Stochastic Oscillator 75.49 22.94

Price Performance

Historical Comparison
ATLO
CRBP

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: